Press & Newsroom

On this page, members of the press can find our press coverage and publications, as well as the latest news from our company.

About QuickBird Medical

QuickBird Medical is a Munich-based company specializing in the development of software for the medical sector. Our team of 30 experts in the fields of development, user experience and regulatory affairs works closely together to create digital solutions for modern and improved healthcare.

We support our clients in areas such as the development of digital health applications (DiGA), medical software that assists physicians in decision-making and embedded software for medical devices. In doing so, we place particular emphasis on quality, regulatory compliance, and clear benefits for patients and healthcare professionals.

Your Contact Person

Malte Bucksch, Managing Director of QuickBird Medical

Malte Bucksch
Managing Director
kontakt@quickbirdmedical.com

QuickBird Medical in Numbers

35+

MEDICAL SOFTWARE PROJECTS

… successfully implemented for customers.

15+

DIGA PROJECTS

…supported with technical, regulatory and strategic expertise.

25+

CLINICAL CONDITIONS

…which we address with digital applications.

15+

COUNTRIES

…in which software we have developed is in use.

QuickBird Medical in the Press

GTAI Digital Doctoring

Interview · Germany Trade & Invest

Digital Doctoring – Germany as a Growth Market

June 2026

READ THE ARTICLE
Pharma Relations

Feature Article · Pharma Relations

Time for a Major Communications Campaign

May 2025

READ THE ARTICLE
DiGA Talk

Podcast · DiGA Talk

Digital Health Applications – Where Are We Headed?

September 2024

READ THE ARTICLE
APM Health Europe

Interview · APM Health Europe

No HTA Standard for Health Apps in Germany

July 2024

READ THE ARTICLE
Pharma Relations

Guest Column · Pharma Relations

DiGA: The Unknown (Healthcare) Entity?

January 2024

READ THE ARTICLE
Health Relations

Interview · Health Relations

DiGA Marketing: Specialized Sales Force Plays an Important Role

January 2024

READ THE ARTICLE
hr info

Interview · hr info

Data Protection or Pandemic Control?

July 2020

READ THE ARTICLE
hr info

Interview · Südtiroler Tageszeitung

Interview with Stefan Kofler on COVID-19 Apps

July 2020

READ THE ARTICLE
Pharma Relations

Interview · Pharma Relations

The Potential of Digital Health Applications

March 2019

READ THE ARTICLE
GTAI Digital Doctoring Relations

Interview · Germany Trade & Invest

Digital Doctoring – Germany as a Growth Market

June 2026

READ THE ARTICLE
Pharma Relations

Feature Article · Pharma Relations

Time for a Major Communications Campaign

May 2025

READ THE ARTICLE
Pharma Relations

Podcast · DiGA Talk

Digital Health Applications – Where Are We Headed?

September 2024

READ THE ARTICLE
Pharma Relations

Interview · APM Health Europe

No HTA Standard for Health Apps in Germany

July 2024

READ THE ARTICLE
Pharma Relations

Guest Column · Pharma Relations

DiGA: The Unknown (Healthcare) Entity?

January 2024

READ THE ARTICLE
Health Relations

Interview · Health Relations

DiGA Marketing: Specialized Sales Force Plays an Important Role

January 2024

READ THE ARTICLE
hr info

Interview · hr info

Data Protection or Pandemic Control?

July 2020

READ THE ARTICLE
South Tyrolean Daily Newspaper

Interview · Südtiroler Tageszeitung

Interview with Stefan Kofler on COVID-19 Apps

July 2020

READ THE ARTICLE
Pharma Relations

Interview · Pharma Relations

The Potential of Digital Health Applications

April 2019

Company News

Telekom TechBoost Stefan Kofler

News

QuickBird Medical at T-Systems’ T Cloud Partner Day

September 2026

READ THE ARTICLE
BSI TR-03161 News

News

QuickBird Medical: Two New BSI Certificates for DiGA Projects

June 2026

READ THE ARTICLE
BSI TR-03161 News

News

QuickBird Medical at DMEA 2026

April 2026

READ THE ARTICLE
BSI TR-03161 News

Presentation

Keynote Presentation at Pharma Deutschland: Opportunities for Telemonitoring DiGA

April 2026

READ THE ARTICLE
BSI TR-03161 News

News

88% Therapy Success: Vertigo App Vertidisan Outperforms Conventional Physiotherapy

April 2026

READ THE ARTICLE
BSI TR-03161 News

Press Release

QuickBird Medical Successfully Completes BSI TR-03161 Certification for Its Second DiGA

March 2026

READ THE ARTICLE
MEDICA 2025

News

Digital Health in Germany – Presentation by QuickBird Medical at MEDICA 2025

November 2025

READ THE ARTICLE
Oriko News

Press Release

QuickBird Medical Wins ENDO-EVE Project Funded by the Innovation Fund

September 2025

READ THE ARTICLE
Oriko News

Press Release

ORIKO®: First DiGA for ADHD in Adults Listed – Developed by QuickBird Medical

July 2025

READ THE ARTICLE
DiGA Directory

Press Release

QuickBird Medical Releases Updated DiGA Analysis Tool for Manufacturers

July 2025

READ THE ARTICLE
Oriko News

Press Release

First BSI TR-03161 Certification for DiGA: QuickBird Medical Reaches Important Milestone

June 2025

READ THE ARTICLE
Oriko News

Press Release

App for People with Mental Illness: QuickBird Medical Wins Europe-Wide Tender

February 2025

READ THE ARTICLE
QuickBird Medical team visiting the THERY gait robot

Press Release

THERY Walking Robot Receives CE Marking – QuickBird Medical Supplies Software

January 2025

READ THE ARTICLE
digital health events

Press Release

5 Years of digital-health-events.de: The Platform for Digital Health Events in Germany

September 2024

READ THE ARTICLE
Cannabis Research

Press Release

QuickBird Medical Develops Digital Study Platform for Switzerland’s Largest Cannabis Study

June 2024

READ THE ARTICLE
digital health events

Press Release

QuickBird Medical Wins INTEGRATE-ATMP Project Funded by the Innovation Fund

June 2023

READ THE ARTICLE
Telekom TechBoost Stefan Kofler

News

QuickBird Medical at T-Systems’ T Cloud Partner Day

September 2026

READ THE ARTICLE
QuickBird Medical BSI Certificates

News

QuickBird Medical: Two New BSI Certificates for DiGA Projects

June 2026

READ THE ARTICLE
QuickBird Medical at DMEA 2026

News

QuickBird Medical at DMEA 2026

April 2026

READ THE ARTICLE
Telemonitoring DiGA

Presentation

Keynote Presentation at Pharma Deutschland: Opportunities for Telemonitoring DiGA

April 2026

READ THE ARTICLE
Vertidisan

News

88% Therapy Success: Vertigo App Vertidisan Outperforms Conventional Physiotherapy

April 2026

READ THE ARTICLE
MEDICA 2025

Press Release

QuickBird Medical Successfully Completes BSI TR-03161 Certification for Its Second DiGA

March 2026

READ THE ARTICLE
MEDICA 2025

News

Digital Health in Germany – Presentation by QuickBird Medical at MEDICA 2025

November 2025

READ THE ARTICLE
Endo-EVE

Press Release

QuickBird Medical Wins ENDO-EVE Project Funded by the Innovation Fund

September 2025

READ THE ARTICLE
Pharma Relations

Press Release

ORIKO®: First DiGA for ADHD in Adults Listed – Developed by QuickBird Medical

July 2025

READ THE ARTICLE
DiGA Directory

Press Release

QuickBird Medical Releases Updated DiGA Analysis Tool for Manufacturers

July 2025

READ THE ARTICLE
Pharma Relations

Press Release

First BSI TR-03161 Certification for DiGA: QuickBird Medical Reaches Important Milestone

June 2025

READ THE ARTICLE
Pharma Relations

Press Release

App for People with Mental Illness: QuickBird Medical Wins Europe-Wide Tender

February 2025

READ THE ARTICLE
QuickBird Medical team visiting the THERY gait robot

Press Release

THERY Walking Robot Receives CE Marking – QuickBird Medical Supplies Software

January 2025

READ THE ARTICLE
digital health events

Press Release

5 Years of digital-health-events.de: The Platform for Digital Health Events in Germany

September 2024

READ THE ARTICLE
Cannabis Research

Press Release

QuickBird Medical Develops Digital Study Platform for Switzerland’s Largest Cannabis Study

June 2024

READ THE ARTICLE
Cannabis Research

Press Release

QuickBird Medical Wins INTEGRATE-ATMP Project Funded by the Innovation Fund

June 2023

READ THE ARTICLE

Our Clients

Are you planning to implement Medical Software
or a DiGA?

Contact us for a free initial consultation. We’ll provide you with an estimate of the effort and timeline required to implement your project. As part of this process, we’ll also review the regulatory and strategic framework for your product.